Skip to main content
UCL Ventures Navigate back to homepage
Find your Business Manager

Main navigation

  • Your route to market

    Your route to market

    We guide UCL academics, researchers and clinicians to get their research to market.

    Disclose an idea
    • Getting started An introduction to commercialisation and next steps
    • Our collaborative approach How we work with you to get to market
    • What you can expect Demystifying the process of commercialisation
    • Options to move forwards Explore the different pathways to market
      • Protect your idea
      • Create a company
      • Licensing your invention
      • Routes to social impact
    • Funding & support The financial and practical help that we can offer
      • Help managing your project
      • Training & tools
      • Common questions
  • Explore innovations

    Explore innovations

    Our portfolio and technologies span AI and quantum, to gene therapies to consumer products.

    • Spinout portfolio Browse our portfolio of spinout companies, based on UCL research
    • Our expertise & pipeline The sectors we span and therapeutics in development
    • Social Ventures Ventures driving impact in communities
    • License a technology Opportunities & collaborations with UCL's world-class research
  • Global impact

    Global impact

    How UCL research is changing the way the world lives, works and thrives.

    • Inspiring stories Real-world impact and successes, supported by UCL Ventures
    • Impact Report Our annual report showcases how UCL research is going beyond the university
    • Supporting innovation at UCL Understand our role in the innovation ecosystem
  • Investors & business

    Investors & business

    Opportunities for collaboration across UCL's world-class research

    • Why partner with UCL Ventures With over 30 years in commercialisation, we have a strong track record
    • Our portfolio View our spinout companies across all sectors
  • News & events

    News & events

    The latest news and events from our team and portfolio

    • Current page: News & views Stay up to date with the latest insights and announcements
    • Events Where you can find us across UCL and external events
  • Get in touch

    Get in touch

    Contact our team of experts for all your queries and needs

    • Speak to the team Choose your enquiry type to reach the right team
Find your Business Manager

CogStack launches its AI technology to transform global healthcare data

A way to gain deeper insights from records

3 December 2025

Breadcrumb trail

  1. Home
  2. News & events
  3. News & views
  4. CogStack launches its AI technology to transform global healthcare data

CogStack, a spinout venture born from collaboration between UCL, King’s College London and a coalition of leading NHS Foundation Trusts, has launched its innovative AI-driven platform which is set to accelerate digital transformation across the NHS and international healthcare systems.

CogStack’s mission is to improve data quality and utilisation to enhance patient care, safety, population health, and clinical research.

Its AI platform uses natural language processing (NLP) to generate deep insights from patient health records, supporting clinical decision making and healthcare research. The platform can search any structured or unstructured clinical data and assign diagnostic or treatment codes and medical meaning, based on particular words and sentences. Its models are trained on records from millions of real-world patients and fine-tuned by hundreds of thousands of clinician-supplied labels.

CogStack has been adopted by hospitals across London and in Birmingham, Leeds, Liverpool, Manchester, Southampton, Lancashire, and further afield in hospitals in Asia, Australia and Europe.

It has already brought about significant benefits in physical and mental health care through workforce productivity and automating data tasks:

- Fast-tracking recruitment for clinical trials – CogStack was cited as a key enabler for accelerated recruitment for the ‘100k Genome’ project, which needed patients with suspected rare diseases.
- Enhanced data efficiency – King’s College Hospital detected thousands of missing records of fracture clinic procedures in only 30 minutes.
- Accelerated medication reviews – saving more than two hours per pharmacy review at South London and Maudsley NHS Foundation Trust.
- Improved patient safety – University College London Hospital was alerted to 100’s of patients who were ‘lost-to-follow-up’ in their healthcare journey in a gastroenterology clinic.
- Improved accuracy in clinical coding – at Guy’s and St Thomas’ Hospital outpatient procedures, delivering £2.5m in additional income to NHS Foundation Trust in 2023.

UCL Ventures supported the commercialisation journey of CogStack from its early research roots, helping secure IP, navigate funding pathways and connect with NHS partners.

Dr. Alberto Gatta, Business Manager, UCL Ventures, said: “The launch of CogStack reflects the collaborative efforts of UCLH BRC, UCL Ventures, and King’s Health Partners, underlining our shared commitment to advancing research into practical solutions for the NHS and beyond. It is thrilling to see how our concerted work is now facilitating the delivery of cutting-edge AI tools that enhance clinical workflows and enable better and more efficient use of health data for patient benefit.”

Prof Karl Peggs, Director of the NIHR UCLH BRC, said: “Congratulations to Richard and the whole team on the establishment of Cogstack as a new collaborative venture. This AI technology has already made a huge impact in the places it has been applied, and there is huge potential for impact in the future, in the UK and internationally. The establishment of Cogstack Ltd will fuel that further development and reach, and is a prime example of the important role that NIHR BRCs can play by investing in exciting science and supporting its commercialisation.”

Professor James Teo, CogStack’s Chief Medical Officer, added: “As a trusted, home-grown NHS innovation, CogStack is easy to deploy and delivers medically intelligent analytics at low cost. We aim to expand its capabilities to more NHS trusts and new markets.”

UCL Ventures footer

About UCL Ventures

  • Our people
  • What we do
  • Who we are
  • Our culture

Forms & Resources

  • Publications and downloads

Accreditations

  • Cyber essentials
    cyber essentials logo
  • Living wage
    living wage employer logo
UCL Ventures

UCL Ventures Limited (Company Registration No: 02776963) is a wholly-owned subsidiary of University College London. 

Registered office: 
University College London
Gower Street
London
WC1E 6BT

UCL social media menu

  • Link to Linkedin
Back to top

Legal

  • Cookie policy
  • Freedom of information
  • Privacy policy
  • Rules of website use

© 2026 UCL Business Ltd